Ortega-Alonzo SE, Hinojosa-Lezama JM

Language: Spanish
References: 30
Page: 203-207
PDF size: 209.91 Kb.

ABSTRACT

A clinical case is presented of a six-year old male with recurrent episodes of macroscopic hematuria, mostly associated to upper respiratory tract infections. Secondary involvement is discarded and handled with clinically suspected primary IgA Nephropathy, low risk to progression to end-stage renal disease. Even though it is relatively frequent disease, is rarely diagnosed by the first contact physician. In this report, it is informed about the advances in the pathophysiology and diagnosis of this entity, the clinical and histopathological aspects of the pediatric patient with renal disease, the dilemma on the diagnostic approach to invasive renal biopsy in a life-long disease that begins in a short age, the prognosis and treatment of the patient with hematuria of glomerular origin.

REFERENCES

1. Wyatt RJ, Julian BA. IgA nephropathy. N Engl J Med. 2013; 368(25): 2402-2414.

2. Chávez VV, Orizaga CC, Becerra FJG, Fuentes RF, Parra MR, Aragaki Y et al. Epidemiología de la enfermedad glomerular en adultos. Revisión de una base de datos. Gac Med Mex. 2014; 150: 403-408.

3. Hanko JB, Mullan RN, O’Rourke DM, McNamee PT, Maxwell AP, Courtney AE. The changing pattern of adult primary glomerular disease. Nephrol Dial Transplant. 2009; 24(10): 3050-3054.

4. Swaminathan S, Leung N, Lager DJ, Melton LJ, Bergstralh EJ, Rohlinger A et al. Changing incidence of glomerular disease in Olmsted County, Minnesota: a 30-year renal biopsy study. Clin J Am Soc Nephrol. 2006; 1(3): 483-487.

5. Berger J, Hinglais N. Intercapillary deposits of IgA-IgG. J Urol Nephrol. 1968; 74: 694-695.

6. Feehally J, Cameron JS. IgA nephropathy: progress before and since berger. Am J Kidney Dis. 2011; 58(2): 310-319.

7. Novak J, Julian BA, Mestecky J, Renfrow MB. Glycosylation of IgA1 and pathogenesis of IgA nephropathy. Semin Immunopathol. 2012; 34(3): 365-382.

8. Salvadori M, Rosso G. Update on immunoglobulin A nephropathy, Part I: pathophysiology. World J Nephrol. 2015; 4(4): 455-467.

9. Floege J, Gröne H. IgA-nephropathy: frequent, but rarely diagnosed. Internist (Berl). 2003; 44(9): 1131-1139.

10. Hicks J, Mierau G, Wartchow E, Eldin K. Renal diseases associated with hematuria in children and adolescents: a brief tutorial. Ultrastruct Pathol. 2012; 36(1): 1-18.

11. Choyke PL. Radiologic evaluation of hematuria: guidelines from the American College of Radiology’s appropriateness criteria. Am Fam Physician. 2008; 78(3): 347-352.

12. Moloney F, Murphy K, Twomey M, O’Connor O, Maher M. Haematuria: an imaging guide. Adv Urol. 2014; 2014: 414125.

13. Davis TK, Hmiel P. Pediatric hematuria remains a clinical dilemma. Clin Pediatr. 2015; 54(9): 817-830.

14. Salvadori M, Rosso G. Update on immunoglobulin A nephropathy, Part II: clinical, diagnostic and therapeutic aspects. World J Nephrol. 2016; 5(1): 6-19.

15. Yu HH, Chiang BL. Diagnosis and classification of IgA nephropathy. Autoimmun Rev. 2014; 13(4-5): 556-559.

16. Coppo R, Davin JC. The difficulty in considering modifiable pathology risk factors in children with IgA nephropathy: crescents and timing of renal biopsy. Pediatr Nephrol. 2014; 30(2): 189-192.

17. Moresco RN, Speeckaert MM, Delanghe JR. Diagnosis and monitoring of IgA nephropathy: The role of biomarkers as an alternative to renal biopsy. Autoimmun Rev. 2015; 14(10): 847-853.

18. Brachemi S, Bollée G. Renal biopsy practice: What is the gold standard? World J Nephrol. 2014; 3(4): 287-294.

19. Peters B, Stegmayr B, Andersson Y, Hadimeri H, Mölne J. Increased risk of renal biopsy complications in patients with IgA-nephritis. Clin Exp Nephrol. 2015; 19(6): 1135-1141.

20. Shima Y, Nakanishi K, Hama T, Sato M, Mukaiyama H, Togawa H et al. Biopsy timing and Oxford classification variables in Childhood/Adolescent IgA nephropathy. Pediatr Nephrol. 2015; 30(2): 293-299.

21. Feng CY, Xia YH, Wang WJ, Xia J, Fu HD, Wang X et al. Persistent asymptomatic isolated hematuria in children: Clinical and histopathological features and prognosis. World J Pediatr. 2013; 9(2): 163-168.

22. Wang T, Ye F, Meng H, Zhang L, Jin X. Comparison of clinicopathological features between children and adults with IgA nephropathy. Pediatr Nephrol. 2012; 27(8): 1293-1300.

23. Julian BA, Wittke S, Haubitz M, Zürbig P, Schiffer E, McGuire BM et al. Urinary biomarkers of IgA nephropathy and other IgA-associated renal diseases. World J Urol. 2007; 25(5): 467-476.

24. Suzuki Y, Suzuki H, Makita Y, Takahata A, Takahashi K, Muto M et al. Diagnosis and activity assessment of immunoglobulin A nephropathy: current perspectives on noninvasive testing with aberrantly glycosylated immunoglobulin A-related biomarkers. Int J Nephrol Renovasc Dis. 2014; 7: 409-414.

25. Coppo R, Troyanov S, Bellur S, Cattran D, Cook HT, Feehally J et al. Validation of the Oxford classification of IgA nephropathy in cohorts with different presentations and treatments. Kidney Int. 2014; 86(4): 828-836.

26. Tanaka K, Moriyama T, Iwasaki C, Takei T, Nitta K. Effect of hematuria on the outcome of IgA nephropathy with mild proteinuria. Clin Exp Nephrol. 2014; 19(5): 815-821.

27. Barakat AJ. Presentation of the child with renal disease and guidelines for referral to the pediatric nephrologist. Int J Pediatr. 2012; 2012(2): 1-5.

28. Smart NA, Dieberg G, Ladhani M, Titus T. Early referral to specialist nephrology services for preventing the progression to end-stage kidney disease. Cochrane Database Syst Rev. 2014; 6(6): CD007333.

29. Group KW. KDIGO clinical practice guideline for glomerulonephritis. Kidney Int Suppl. 2012; 2(2): 1-274.

30. Wang Y, Chen J, Wang Y, Chen Y, Wang L, Lv Y. A meta-analysis of the clinical remission rate and long-term efficacy of tonsillectomy in patients with IgA nephropathy. Nephrol Dial Transplant. 2011; 26: 1923-1931.